2857.6500 -22.70 (-0.79%)
NSE Apr 01, 2025 12:16 PM
Volume: 33,034
 

2857.65
-0.79%
Sharekhan
steady operating performance with revenue growing by ~8% (driven by 5.4% volume growth). Strong expansion in EBIDTA margins and higher other income led to strong bottom-line growth. Horlicks continued to maintain its leadership in the Health Food Drinks (HFD) category with 44% market share. Premium products gaining good traction coupled with new product launches and improving penetration will be key revenue drivers going ahead. The integration of GSK Consumer and Hindustan Unilever (HUL) will take place by...
GlaxoSmithKline Pharmaceuticals Ltd. has gained 46.80% in the last 1 Year
More from GlaxoSmithKline Pharmaceuticals Ltd.
Recommended